1. Home
  2. NEXA vs GERN Comparison

NEXA vs GERN Comparison

Compare NEXA & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEXA
  • GERN
  • Stock Information
  • Founded
  • NEXA 1956
  • GERN 1990
  • Country
  • NEXA Luxembourg
  • GERN United States
  • Employees
  • NEXA N/A
  • GERN N/A
  • Industry
  • NEXA Metal Mining
  • GERN Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEXA Basic Materials
  • GERN Health Care
  • Exchange
  • NEXA Nasdaq
  • GERN Nasdaq
  • Market Cap
  • NEXA 741.7M
  • GERN 823.0M
  • IPO Year
  • NEXA 2017
  • GERN 1996
  • Fundamental
  • Price
  • NEXA $5.56
  • GERN $1.20
  • Analyst Decision
  • NEXA Hold
  • GERN Buy
  • Analyst Count
  • NEXA 5
  • GERN 7
  • Target Price
  • NEXA $6.20
  • GERN $3.17
  • AVG Volume (30 Days)
  • NEXA 117.6K
  • GERN 7.1M
  • Earning Date
  • NEXA 10-30-2025
  • GERN 11-05-2025
  • Dividend Yield
  • NEXA 1.82%
  • GERN N/A
  • EPS Growth
  • NEXA N/A
  • GERN N/A
  • EPS
  • NEXA N/A
  • GERN N/A
  • Revenue
  • NEXA $2,839,970,000.00
  • GERN $164,447,000.00
  • Revenue This Year
  • NEXA $2.73
  • GERN $172.62
  • Revenue Next Year
  • NEXA $2.04
  • GERN $56.87
  • P/E Ratio
  • NEXA N/A
  • GERN N/A
  • Revenue Growth
  • NEXA 6.95
  • GERN 11877.20
  • 52 Week Low
  • NEXA $4.44
  • GERN $1.09
  • 52 Week High
  • NEXA $9.61
  • GERN $4.50
  • Technical
  • Relative Strength Index (RSI)
  • NEXA 57.96
  • GERN 41.38
  • Support Level
  • NEXA $5.41
  • GERN $1.19
  • Resistance Level
  • NEXA $5.71
  • GERN $1.31
  • Average True Range (ATR)
  • NEXA 0.25
  • GERN 0.06
  • MACD
  • NEXA -0.00
  • GERN -0.00
  • Stochastic Oscillator
  • NEXA 46.77
  • GERN 8.33

About NEXA Nexa Resources S.A.

Nexa Resources SA is a low-cost integrated zinc producer. It produces copper, silver, and gold as byproducts. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: